Home›Companies›Biotech & Pharma›Aevumed

Aevumed Inc.

Updated Oct 29, 2026·Latest SEC filing Jun 12, 2025·Suggest an edit

About Aevumed

Aevumed is a private company based in Malvern, Pennsylvania. It has reported $5,069,000 raised in four offerings on Form D since June 2025. Its chief executive is Saif Khalil.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 21, 2021Jun 12, 2025$3,000,000fully sold36$83,333EquityRule 506(b)Form D ↗
Sep 28, 2020Jun 12, 2025$1,500,000fully sold21$71,429EquityRule 506(b)Form D ↗
Apr 19, 2018Jun 12, 2025$264,000fully sold10$26,400EquityRule 506(b)Form D ↗
Nov 12, 2013Jun 12, 2025$305,000fully sold10$30,500Debt, OptionsRule 506(b)Form D ↗
Total, four offerings$5,069,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aevumed's Form D filed Jun 12, 2025.

DF
David Farmer
Director
SK
Saif Khalil
CEO and director
WS

Sources

  1. SECAevumed Inc. filing history